Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The 10mg vial is designed for multi-session research programs or dose-escalation studies that require consistent quantities of Retatrutide across many experimental sessions
The ongoing trial, SURPASS-CVOT, is expected to provide definitive evidence on the cardiovascular safety and efficacy of tirzepatide as compared with dulaglutide, which has established cardiovascular benefits
The app does not replace the visit
- Side Effects: The most common side effects were gastrointestinal, such as nausea and diarrhea, generally mild to moderate
US$ 21.34
US$ 26.83
US$ 20.74
